FRONTIER CAPITAL MANAGEMENT CO LLC Cytokinetics, Incorporated Transaction History

FRONTIER CAPITAL MANAGEMENT CO LLC portfolio value:

$7.71M
portfolio value

FRONTIER CAPITAL MANAGEMENT CO LLC quarter portfolio value change:

+23.31%
quarter

Cytokinetics, Incorporated 13F transactions

Quarter Transaction type Change Relative change Absolute change Change value Avg. price Shares
Q3 2022 share Increase +180.02% 102.35K shares 5.48M $48.45 159.21K
Q2 2022 share Decrease -86.12% -352.69K shares -12.84M $39.29 56.85K
Q1 2022 share Decrease -38.02% -251.26K shares -15.04M $36.81 409.55K
Q4 2021 share Decrease -12.53% -94.62K shares 3.12M $45.6 660.81K
Q3 2021 share Increase 0.00% 755.43K shares 26.99M $35.74 755.43K